KELLY WULF: Open Payments
NPI 1750654323 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$636 in 32 payments from 8 companies in 2025. Trend: 2023 $883 · 2024 $632 · 2025 $636
Food & beverage: $561Education: $75
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $206 |
| Lilly USA, LLC | 14 | $178 |
| Novartis Pharmaceuticals Corporation | 5 | $96 |
| Regeneron Healthcare Solutions, Inc. | 3 | $67 |
| ABBVIE INC. | 2 | $35 |
| GENZYME CORPORATION | 1 | $30 |
| UCB, Inc. | 1 | $19 |
| Organon LLC | 1 | $6 |
Products named: TREMFYA, TALTZ, DUPIXENT, COSENTYX, RINVOQ, Bimzelx.
Industry payments across OR — which companies pay providers there.
